Development of antibody-based therapeutics: translational considerations
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York ; Heidelberg ; Dordrecht ; London
Springer
2012
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturangaben |
| Beschreibung: | xiv, 425 Seiten Illustrationen, Diagramme 235 mm x 155 mm |
| ISBN: | 9781489991133 9781441959539 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV043601418 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 160614s2012 a||| |||| 00||| eng d | ||
| 010 | |a 2012936109 | ||
| 015 | |a 09N511321 |2 dnb | ||
| 016 | 7 | |a 998589756 |2 DE-101 | |
| 020 | |a 9781489991133 |9 978-1-4899-9113-3 | ||
| 020 | |a 9781441959539 |c GB. : ca. EUR 165.74 (freier Pr.), ca. sfr 240.50 (freier Pr.) |9 978-1-4419-5953-9 | ||
| 035 | |a (OCoLC)836872945 | ||
| 035 | |a (DE-599)DNB998589756 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 050 | 0 | |a RM282.M65 | |
| 082 | 0 | |a 616.07/98 | |
| 084 | |a VS 9400 |0 (DE-625)147728:253 |2 rvk | ||
| 084 | |a 44.40 |2 bkl | ||
| 084 | |a 44.38 |2 bkl | ||
| 245 | 1 | 0 | |a Development of antibody-based therapeutics |b translational considerations |c Mohammad A. Tabrizi, Gadi G. Bornstein, Scott L. Klakamp, editors |
| 264 | 1 | |a New York ; Heidelberg ; Dordrecht ; London |b Springer |c 2012 | |
| 300 | |a xiv, 425 Seiten |b Illustrationen, Diagramme |c 235 mm x 155 mm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben | ||
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antikörper |0 (DE-588)4002290-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Antikörper |0 (DE-588)4002290-0 |D s |
| 689 | 0 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Tabrizi, Mohammad A. |e Sonstige |4 oth | |
| 700 | 1 | |a Bornstein, Gadi G. |e Sonstige |4 oth | |
| 700 | 1 | |a Klakamp, Scott L. |e Sonstige |4 oth | |
| 856 | 4 | |m DE-601 |q pdf/application |u http://www.gbv.de/dms/bs/toc/61469275X.pdf |3 Inhaltsverzeichnis | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029015591 | ||
Datensatz im Suchindex
| _version_ | 1804176345344770048 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043601418 |
| callnumber-first | R - Medicine |
| callnumber-label | RM282 |
| callnumber-raw | RM282.M65 |
| callnumber-search | RM282.M65 |
| callnumber-sort | RM 3282 M65 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | VS 9400 |
| ctrlnum | (OCoLC)836872945 (DE-599)DNB998589756 |
| dewey-full | 616.07/98 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.07/98 |
| dewey-search | 616.07/98 |
| dewey-sort | 3616.07 298 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01729nam a2200469 c 4500</leader><controlfield tag="001">BV043601418</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">160614s2012 a||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2012936109</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">09N511321</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">998589756</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781489991133</subfield><subfield code="9">978-1-4899-9113-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781441959539</subfield><subfield code="c">GB. : ca. EUR 165.74 (freier Pr.), ca. sfr 240.50 (freier Pr.)</subfield><subfield code="9">978-1-4419-5953-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)836872945</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB998589756</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM282.M65</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.07/98</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9400</subfield><subfield code="0">(DE-625)147728:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Development of antibody-based therapeutics</subfield><subfield code="b">translational considerations</subfield><subfield code="c">Mohammad A. Tabrizi, Gadi G. Bornstein, Scott L. Klakamp, editors</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York ; Heidelberg ; Dordrecht ; London</subfield><subfield code="b">Springer</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 425 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">235 mm x 155 mm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antikörper</subfield><subfield code="0">(DE-588)4002290-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antikörper</subfield><subfield code="0">(DE-588)4002290-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tabrizi, Mohammad A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bornstein, Gadi G.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klakamp, Scott L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="m">DE-601</subfield><subfield code="q">pdf/application</subfield><subfield code="u">http://www.gbv.de/dms/bs/toc/61469275X.pdf</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029015591</subfield></datafield></record></collection> |
| id | DE-604.BV043601418 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:30:42Z |
| institution | BVB |
| isbn | 9781489991133 9781441959539 |
| language | English |
| lccn | 2012936109 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029015591 |
| oclc_num | 836872945 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | xiv, 425 Seiten Illustrationen, Diagramme 235 mm x 155 mm |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | Springer |
| record_format | marc |
| spelling | Development of antibody-based therapeutics translational considerations Mohammad A. Tabrizi, Gadi G. Bornstein, Scott L. Klakamp, editors New York ; Heidelberg ; Dordrecht ; London Springer 2012 xiv, 425 Seiten Illustrationen, Diagramme 235 mm x 155 mm txt rdacontent n rdamedia nc rdacarrier Literaturangaben Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Antikörper (DE-588)4002290-0 gnd rswk-swf Antikörper (DE-588)4002290-0 s Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Tabrizi, Mohammad A. Sonstige oth Bornstein, Gadi G. Sonstige oth Klakamp, Scott L. Sonstige oth DE-601 pdf/application http://www.gbv.de/dms/bs/toc/61469275X.pdf Inhaltsverzeichnis |
| spellingShingle | Development of antibody-based therapeutics translational considerations Arzneimittelentwicklung (DE-588)4143176-5 gnd Antikörper (DE-588)4002290-0 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4002290-0 |
| title | Development of antibody-based therapeutics translational considerations |
| title_auth | Development of antibody-based therapeutics translational considerations |
| title_exact_search | Development of antibody-based therapeutics translational considerations |
| title_full | Development of antibody-based therapeutics translational considerations Mohammad A. Tabrizi, Gadi G. Bornstein, Scott L. Klakamp, editors |
| title_fullStr | Development of antibody-based therapeutics translational considerations Mohammad A. Tabrizi, Gadi G. Bornstein, Scott L. Klakamp, editors |
| title_full_unstemmed | Development of antibody-based therapeutics translational considerations Mohammad A. Tabrizi, Gadi G. Bornstein, Scott L. Klakamp, editors |
| title_short | Development of antibody-based therapeutics |
| title_sort | development of antibody based therapeutics translational considerations |
| title_sub | translational considerations |
| topic | Arzneimittelentwicklung (DE-588)4143176-5 gnd Antikörper (DE-588)4002290-0 gnd |
| topic_facet | Arzneimittelentwicklung Antikörper |
| url | http://www.gbv.de/dms/bs/toc/61469275X.pdf |
| work_keys_str_mv | AT tabrizimohammada developmentofantibodybasedtherapeuticstranslationalconsiderations AT bornsteingadig developmentofantibodybasedtherapeuticstranslationalconsiderations AT klakampscottl developmentofantibodybasedtherapeuticstranslationalconsiderations |